Cancer stem cells (CSCs) are cancer cells (found within tumors or hematological cancers) that possess characteristics associated with normal stem cells, specifically the ability to give rise to all cell types found in a particular cancer sample. CSCs are therefore tumorigenic (tumor-forming), perhaps in contrast to other non-tumorigenic cancer cells. CSCs may generate tumors through the stem cell processes of self-renewal and differentiation into multiple cell types. Such cells are proposed to persist in tumors as a distinct population and cause relapse and metastasis by giving rise to new tumors. Therefore, development of specific therapies targeted at CSCs holds hope for improvement of survival and quality of life of cancer patients, especially for patients with metastatic disease.
Existing cancer treatments have mostly been developed based on animal models, where therapies able to promote tumor shrinkage were deemed effective. However, animals could not provide a complete model of human disease. In particular, in mice, whose life spans do not exceed two years, tumor relapse is exceptionally difficult to study.
The efficacy of cancer treatments is, in the initial stages of testing, often measured by the ablation fraction of tumor mass (fractional kill). As CSCs would form a very small proportion of the tumor, this may not necessarily select for drugs that act specifically on the stem cells. The theory suggests that conventional chemotherapies kill differentiated or differentiating cells, which form the bulk of the tumor but are unable to generate new cells. A population of CSCs, which gave rise to it, could remain untouched and cause a relapse of the disease.
Cancer stem cells were first identified by John Dick in acute myeloid leukemia in the late 1990s. As a stem cell biologist interested in blood stem cells, Dick was fortunate in his choice of cancer to study, picking one of the types where cancer stem cells have proved to have an especially important role. Since the early 2000s they have been an intense focus of cancer research[1]
In different tumor subtypes, cells within the tumor population exhibit functional heterogeneity, and tumors are formed from cells with various proliferative and differentiate capacities.[2] This functional tumour heterogeneity among cancer cells has led to the creation of at least two models, which have been put forward to account for heterogeneity and differences in tumor-regenerative capacity: the cancer stem cell (CSC) and clonal evolution models[3]
The cancer stem cell model refers to a subset of tumor cells that have the ability to self-renew and are able to generate the diverse tumor cells.[3] These cells have been termed cancer stem cells to reflect their stem-like properties. One implication of the CSC model and the existence of CSCs is that the tumor population is hierarchically arranged with CSCs lying at the apex of the hierarchy[4] (Fig. 3).
The clonal evolution model postulates that mutant tumor cells with a growth advantage are selected and expanded. Cells in the dominant population have a similar potential for initiating tumor growth[5] (Fig. 4).
[6] These two models are not mutually exclusive, as CSCs themselves undergo clonal evolution. Thus, the secondary more dominant CSCs may emerge, if a mutation confers more aggressive properties[7] (Fig. 5).
The existence of CSCs is a subject of debate within medical research, because many studies have not been successful in discovering the similarities and differences between normal tissue stem cells and cancer (stem) cells.[8] Cancer cells must be capable of continuous proliferation and self-renewal in order to retain the many mutations required for carcinogenesis, and to sustain the growth of a tumor since differentiated cells (constrained by the Hayflick Limit[9]) cannot divide indefinitely. However, it is debated whether such cells represent a minority. If most cells of the tumor are endowed with stem cell properties, there is no incentive to focus on a specific subpopulation. There is also debate on the cell of origin of CSCs - whether they originate from normal stem cells that have lost the ability to regulate proliferation, or from more differentiated population of progenitor cells that have acquired abilities to self-renew (which is related to the issue of stem cell plasticity).
The first conclusive evidence for CSCs was published in 1997 in Nature Medicine. Bonnet and Dick[10] isolated a subpopulation of leukaemic cells that expressed a specific surface marker CD34, but lacked the CD38 marker. The authors established that the CD34+/CD38- subpopulation is capable of initiating tumors in NOD/SCID mice that are histologically similar to the donor. The first evidence of a solid tumor cancer stem-like cell followed in 2002 with the discovery of a clonogenic, sphere-forming cell isolated and characterized from human brain gliomas [Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro [Ignatova TN, Kukekov VG, Laywell ED, Suslov ON, Vrionis FD, Steindler DA. Glia. 2002 Sep;39(3):193-206. PMID 12203386 [PubMed - indexed for MEDLINE].
Follow this link:
Cancer stem cell - Wikipedia, the free encyclopedia
- North Idaho resident working on a second chance at life - KREM.com - October 13th, 2022
- The Right-Wing Attempt to Control Higher Ed - The Chronicle of Higher Education - October 13th, 2022
- Therapeutic Solutions International Granted Emergency IND by FDA for Expanded Patient Access to JadiCell Universal Donor Stem Cell for COVID-19 ARDS... - July 19th, 2022
- Hayden resident family determined to keep the fight against multiple sclerosis at home - KREM.com - July 19th, 2022
- Not Smart But Clever? The Return of 'Dumbphones' - WhoWhatWhy - March 25th, 2022
- Therapeutic Solutions International Reports Superior Neurogenesis Induction in Animal Model of Viral Induced Cognitive Dysfunction Compared to other... - August 18th, 2021
- Bodybuilder, 47, looks half his age & claims the trick to his youthful appearance & strength is thinking h... - The US Sun - July 21st, 2021
- Therapeutic Solutions International Reports Regression of Established Tumors by Combining its Cancer Blood Vessel Targeting Immunotherapy with Low... - April 29th, 2021
- Therapeutic Solutions International Uses StemVacs Platform to Generate Personalized Adoptive T Cell Therapy Targeting Cancer Stem Cells - PRNewswire - February 23rd, 2021
- What Nutritionists Need You to Know About Smoke Point and Cooking Oils - msnNOW - October 8th, 2020
- CSL Behring and Seattle Children's Research Institute to Advance Gene Therapy Treatments for Primary Immunodeficiency Diseases | DNA RNA and Cells |... - June 4th, 2020
- Dr. Dori Borjesson named dean of the WSU College of Veterinary Medicine - WSU News - January 25th, 2020
- In Utah, 'saving lives' with breast milk - FRANCE 24 - January 25th, 2020
- Oak Bay's top stories of 2019 - BCLocalNews - January 6th, 2020
- Robotics Industry Insights - Cobots, Raising the Human... - Robotics Online - Robotics Online - December 17th, 2019
- 100 hospitals and health systems with great orthopedic programs | 2019 - Becker's Hospital Review - December 7th, 2019
- Stem Cell Injections Shoulder | Cost of Stem Cell Therapy ... - September 10th, 2019
- News Releases - University of Idaho - May 16th, 2019
- Amniotic Stem Cell Injections, Advanced Muscle Integration ... - August 3rd, 2018
- Stem Cell Treatment Idaho | Stem Cell Treatment Sun Valley ... - September 21st, 2017
- Continuing the debate about right-to-die issues in Appleton - Idaho Statesman - September 4th, 2017
- FDA announces first US gene therapy approval for cancer treatment - East Idaho News - August 31st, 2017
- Idaho National Laboratory - Wikipedia - November 30th, 2016
- Stem Cell Therapy | Stem Cell Treatments | Idaho Falls ... - August 5th, 2016
- Stem cell clinics, FDA, and giant, unapproved for-profit ... - November 1st, 2015
- SlidePlayer - Upload and Share your PowerPoint presentations - November 1st, 2015
- Stem Cell Therapy For Treating Canine Osteoarthritis | The ... - October 19th, 2015
- Umbilical Cord Blood Stem Cells | CancerConnect News - October 1st, 2015
- Brain Facts - Dialogue for Kids (Idaho Public Television) - September 27th, 2015
- Stem Cells | Cornerstone Family Council - July 2nd, 2015
- PPT Stem Cell PowerPoint presentation | free to view ... - May 2nd, 2015
- Stem Cells - The ALS Association - January 17th, 2015
- Stem Cell Therapy For Autism In USA - World Stem Cells, LLC - December 12th, 2014
- COPD Stem Cell Treatment | Analytical Stem Cell - December 2nd, 2014
- Stem Cells and the Future of Regenerative Medicine - August 23rd, 2014
- Idaho Stem Cell Treatment | Stem Cell Treatments - August 22nd, 2014